Dr. Reddy's Laboratories Limited (RDY)
NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
As of 11:13AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 11.57B |
| Enterprise Value | 10.81B |
| Trailing P/E | 17.14 |
| Forward P/E | 19.92 |
| PEG Ratio (5 yr expected) | 3.46 |
| Price/Sales (ttm) | 3.42 |
| Price/Book (mrq) | 3.38 |
| Enterprise Value/Revenue | 3.23 |
| Enterprise Value/EBITDA | 10.20 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.34 |
| 52-Week Change 3 | 27.10% |
| S&P500 52-Week Change 3 | 28.04% |
| 52 Week High 3 | 77.72 |
| 52 Week Low 3 | 53.88 |
| 50-Day Moving Average 3 | 72.68 |
| 200-Day Moving Average 3 | 70.13 |
Share Statistics
| Avg Vol (3 month) 3 | 197.72k |
| Avg Vol (10 day) 3 | 295.13k |
| Shares Outstanding 5 | 166.53M |
| Implied Shares Outstanding 6 | 168.73M |
| Float 8 | 119.83M |
| % Held by Insiders 1 | 0.00% |
| % Held by Institutions 1 | 15.03% |
| Shares Short (Apr 30, 2024) 4 | 751k |
| Short Ratio (Apr 30, 2024) 4 | 4.71 |
| Short % of Float (Apr 30, 2024) 4 | N/A |
| Short % of Shares Outstanding (Apr 30, 2024) 4 | 0.52% |
| Shares Short (prior month Mar 28, 2024) 4 | 625.76k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | 0.49 |
| Forward Annual Dividend Yield 4 | 0.71% |
| Trailing Annual Dividend Rate 3 | 40.00 |
| Trailing Annual Dividend Yield 3 | 58.22% |
| 5 Year Average Dividend Yield 4 | 0.72 |
| Payout Ratio 4 | 11.96% |
| Dividend Date 3 | Aug 11, 2023 |
| Ex-Dividend Date 4 | Jul 07, 2023 |
| Last Split Factor 2 | 2:1 |
| Last Split Date 3 | Sept 07, 2006 |
Financial Highlights
Currency in INR.Fiscal Year
| Fiscal Year Ends | Mar 31, 2024 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 19.95% |
| Operating Margin (ttm) | 20.87% |
Management Effectiveness
| Return on Assets (ttm) | 11.67% |
| Return on Equity (ttm) | 21.77% |
Income Statement
| Revenue (ttm) | 279.16B |
| Revenue Per Share (ttm) | 280.18 |
| Quarterly Revenue Growth (yoy) | 12.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | 81.05B |
| Net Income Avi to Common (ttm) | 55.68B |
| Diluted EPS (ttm) | 4.01 |
| Quarterly Earnings Growth (yoy) | 36.30% |
Balance Sheet
| Total Cash (mrq) | 81.47B |
| Total Cash Per Share (mrq) | 489.26 |
| Total Debt (mrq) | 20.02B |
| Total Debt/Equity (mrq) | 7.14% |
| Current Ratio (mrq) | 2.58 |
| Book Value Per Share (mrq) | 1,684.80 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 45.43B |
| Levered Free Cash Flow (ttm) | 15.07B |
© 2024 Yahoo. All rights reserved.